Journal article
Successful integration of newborn genetic testing into UK routine screening using prospective consent to determine eligibility for clinical trials
- Abstract:
-
Objective INGR1D (INvestigating Genetic Risk for type 1 Diabetes) was a type 1 diabetes (T1D) genetic screening study established to identify participants for a primary prevention trial (POInT, Primary Oral Insulin Trial).
Methods The majority of participants were recruited by research midwives in antenatal clinics from 18 weeks’ gestation. Using the NHS Newborn Bloodspot Screening Programme (NBSP) infrastructure, participants enrolled in INGR1D ha...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 387.2KB, Terms of use)
-
- Publisher copy:
- 10.1136/archdischild-2022-324270
Funding
Bibliographic Details
- Publisher:
- BMJ Publishing Group
- Journal:
- Archives of Disease in Childhood More from this journal
- Volume:
- 108
- Issue:
- 1
- Pages:
- 26-30
- Place of publication:
- England
- Publication date:
- 2022-09-28
- Acceptance date:
- 2022-09-09
- DOI:
- EISSN:
-
1468-2044
- ISSN:
-
0003-9888
- Pmid:
-
36171064
Item Description
- Language:
-
English
- Keywords:
- Pubs id:
-
1281447
- Local pid:
-
pubs:1281447
- Deposit date:
-
2023-07-06
Terms of use
- Copyright holder:
- Bendor-Samuel et al.
- Copyright date:
- 2023
- Rights statement:
- © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record